125 related articles for article (PubMed ID: 23241526)
1. Survival analysis of breast cancer patients using Cox and frailty models.
Faradmal J; Talebi A; Rezaianzadeh A; Mahjub H
J Res Health Sci; 2012 Dec; 12(2):127-30. PubMed ID: 23241526
[TBL] [Abstract][Full Text] [Related]
2. [Clinical characteristics and prognostic factors of female breast cancer patients with 10 or more positive lymph nodes: a report of 128 patients].
Guan Y; Xu BH; Li Q; Zhang P; Zhao LM; Yuan P; Wang JY
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(2):77-81. PubMed ID: 18353207
[TBL] [Abstract][Full Text] [Related]
3. Ascertaining prognosis for breast cancer in node-negative patients with innovative survival analysis.
Chapman JA; Lickley HL; Trudeau ME; Hanna WM; Kahn HJ; Murray D; Sawka CA; Mobbs BG; McCready DR; Pritchard KI
Breast J; 2006; 12(1):37-47. PubMed ID: 16409585
[TBL] [Abstract][Full Text] [Related]
4. Micrometastatic node-positive breast cancer: long-term outcomes and identification of high-risk subsets in a large population-based series.
Truong PT; Lesperance M; Li KH; MacFarlane R; Speers CH; Chia S
Ann Surg Oncol; 2010 Aug; 17(8):2138-46. PubMed ID: 20151215
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of the number of positive lymph nodes in women with T1-2N1 breast cancer treated with mastectomy: should patients with 1, 2, and 3 positive lymph nodes be grouped together?
Dai Kubicky C; Mongoue-Tchokote S
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1200-5. PubMed ID: 23265570
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors in gastric cancer using log-normal censored regression model.
Pourhoseingholi MA; Moghimi-Dehkordi B; Safaee A; Hajizadeh E; Solhpour A; Zali MR
Indian J Med Res; 2009 Mar; 129(3):262-7. PubMed ID: 19491418
[TBL] [Abstract][Full Text] [Related]
7. Recurrence in breast cancer. Analysis with frailty model.
Gohari MR; Mahmoudi M; Mohammed K; Pasha E; Khodabakhshi R
Saudi Med J; 2006 Aug; 27(8):1187-93. PubMed ID: 16883450
[TBL] [Abstract][Full Text] [Related]
8. The lymph node ratio as an independent prognostic factor for non-metastatic node-positive breast cancer recurrence and mortality.
Solak M; Turkoz FP; Keskin O; Aksoy S; Babacan T; Sarici F; Kertmen N; Sever AR; Altundag K
J BUON; 2015; 20(3):737-45. PubMed ID: 26214625
[TBL] [Abstract][Full Text] [Related]
9. A comparison of breast cancer survival among young, middle-aged, and elderly patients in southern Iran using Cox and empirical Bayesian additive hazard models.
Nematolahi S; Ayatollahi SMT
Epidemiol Health; 2017; 39():e2017043. PubMed ID: 29056033
[TBL] [Abstract][Full Text] [Related]
10. Ratios of involved nodes in early breast cancer.
Vinh-Hung V; Verschraegen C; Promish DI; Cserni G; Van de Steene J; Tai P; Vlastos G; Voordeckers M; Storme G; Royce M
Breast Cancer Res; 2004; 6(6):R680-8. PubMed ID: 15535850
[TBL] [Abstract][Full Text] [Related]
11. [Clinical characteristics and survival analysis of 22 cases of pure epithelial breast metaplastic carcinoma].
Meng HM; Yang YF; Qi LQ; Gu L
Zhonghua Zhong Liu Za Zhi; 2013 Jul; 35(7):525-9. PubMed ID: 24257306
[TBL] [Abstract][Full Text] [Related]
12. The prognostic value of lymph node ratio in node-positive breast cancer: a Dutch nationwide population-based study.
Dings PJ; Elferink MA; Strobbe LJ; de Wilt JH
Ann Surg Oncol; 2013 Aug; 20(8):2607-14. PubMed ID: 23536053
[TBL] [Abstract][Full Text] [Related]
13. Impact of the obesity on lymph node status in operable breast cancer patients.
Keskin O; Aksoy S; Babacan T; Sarici F; Kertmen N; Solak M; Turkoz FP; Arik Z; Esin E; Petekkaya I; Altundag K
J BUON; 2013; 18(4):824-30. PubMed ID: 24344004
[TBL] [Abstract][Full Text] [Related]
14. The prognostic influence of multifocality in breast cancer patients.
Pedersen L; Gunnarsdottir KA; Rasmussen BB; Moeller S; Lanng C
Breast; 2004 Jun; 13(3):188-93. PubMed ID: 15177420
[TBL] [Abstract][Full Text] [Related]
15. The lymph node ratio as prognostic factor in node-positive breast cancer.
Voordeckers M; Vinh-Hung V; Van de Steene J; Lamote J; Storme G
Radiother Oncol; 2004 Mar; 70(3):225-30. PubMed ID: 15064006
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of pathological response of primary tumor and metastatic axillary lymph nodes after neoadjuvant chemotherapy for locally advanced breast carcinoma.
Machiavelli MR; Romero AO; Pérez JE; Lacava JA; Domínguez ME; Rodríguez R; Barbieri MR; Romero Acuña LA; Romero Acuña JM; Langhi MJ; Amato S; Ortiz EH; Vallejo CT; Leone BA
Cancer J Sci Am; 1998; 4(2):125-31. PubMed ID: 9554929
[TBL] [Abstract][Full Text] [Related]
17. Lymph node ratio and pN staging in patients with node-positive breast cancer: a report from the Korean breast cancer society.
Ahn SH; Kim HJ; Lee JW; Gong GY; Noh DY; Yang JH; Jung SS; Park HY
Breast Cancer Res Treat; 2011 Nov; 130(2):507-15. PubMed ID: 21858659
[TBL] [Abstract][Full Text] [Related]
18. The impact of method of biopsy on the incidence of breast cancer sentinel lymph node metastases.
Meattini I; Giannotti E; Abdulcadir D; Saieva C; Guerrieri AM; Vanzi E; Scartoni D; Cecchini S; Sanchez LJ; Orzalesi L; Casella D; Bianchi S; Livi L; Nori J
Eur J Surg Oncol; 2014 Mar; 40(3):277-81. PubMed ID: 24388742
[TBL] [Abstract][Full Text] [Related]
19. Functional form of the effect of the numbers of axillary nodes on survival in early breast cancer.
Vinh-Hung V; Burzykowski T; Cserni G; Voordeckers M; Van De Steene J; Storme G
Int J Oncol; 2003 Mar; 22(3):697-704. PubMed ID: 12579326
[TBL] [Abstract][Full Text] [Related]
20. Does the metastatic lymph node ratio influence the disease-free survival of patients with breast cancer: single-center experiences.
Oven Ustaalioglu BB; Bilici A; Kefeli U; Seker M; Yildirim E; Salepci T; Oncel M; Kement M; Gumus M
Oncology; 2010; 79(1-2):105-11. PubMed ID: 21088436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
